ESC Premium Access

Clinical trial updates

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Sponsored by National Lipid Association

Congress Session

About the speaker

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)
16 presentations
1 follower

4 more presentations in this session

Clinical implications for patients at persistent ASCVD risk

Speaker: Doctor J. Saseen (Aurora, US)

Thumbnail

The future of lipid management: new therapies for LDL-C lowering

Speaker: Doctor H. Bays (Louisville, US)

Thumbnail

Post-activity quiz and discussion

Speaker: Doctor P. Morris (Charleston, US)

Thumbnail

Questions and answers / Panel discussion

Thumbnail

Access the full session

Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

Speakers: Doctor C. Ballantyne, Doctor J. Saseen, Doctor H. Bays, Doctor P. Morris
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk